In today’s data-driven healthcare landscape, the value of a therapy extends far beyond its efficacy in clinical trials. Payers, policymakers, and healthcare providers increasingly demand evidence that demonstrates real-world value. This shift has placed Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) at the heart of medical strategy. We explore … [Read more...]